Compare · PHR vs RELX
PHR vs RELX
Side-by-side comparison of Phreesia Inc. (PHR) and RELX PLC PLC (RELX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PHR and RELX operate in Real Estate (Real Estate), so they compete in similar markets.
- RELX is the larger of the two at $62.96B, about 109.1x PHR ($577.3M).
- Over the past year, PHR is down 66.1% and RELX is down 34.9% - RELX leads by 31.1 points.
- PHR has been more active in the news (6 items in the past 4 weeks vs 3 for RELX).
- PHR has more recent analyst coverage (25 ratings vs 12 for RELX).
- Company
- Phreesia Inc.
- RELX PLC PLC
- Price
- $9.32-2.15%
- $34.52-1.78%
- Market cap
- $577.3M
- $62.96B
- 1M return
- -5.23%
- +1.07%
- 1Y return
- -66.05%
- -34.93%
- Industry
- Real Estate
- Real Estate
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- 2015
- News (4w)
- 6
- 3
- Recent ratings
- 25
- 12
Phreesia Inc.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; appointments solution for online appointments, reminders, and referral tracking; and patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and PRO data for approximately 25 specialties; and life sciences solution to deliver targeted and clinically relevant marketing content to patients, as well as COVID-19 product offerings for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was founded in 2005 and is headquartered in Raleigh, North Carolina.
RELX PLC PLC
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Latest PHR
- SEC Form 10-Q filed by Phreesia Inc.
- Phreesia downgraded by Piper Sandler with a new price target
- Phreesia Announces First Quarter Fiscal 2027 Results
- Phreesia Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Principal Accounting Officer Hui Yvonne sold $3,814 worth of shares (431 units at $8.85) as part of a pre-agreed trading plan and covered exercise/tax liability with 325 shares, decreasing direct ownership by 3% to 23,908 units (SEC Form 4) (for tax liability)
- Phreesia downgraded by Wells Fargo with a new price target
- Phreesia downgraded by Barclays with a new price target
- SEC Form DEFA14A filed by Phreesia Inc.
- SEC Form DEF 14A filed by Phreesia Inc.
- Phreesia Inc. filed SEC Form 8-K: Other Events
Latest RELX
- Goldman initiated coverage on RELX
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- Consumers Ready and Comfortable to Share their Medical Information Electronically for Easier Life Insurance Underwriting
- RELX downgraded by Morgan Stanley
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- WEPACK 2026 Concludes on a Record High, Reinforcing China's Role at the Heart of the Global Packaging Industry
- SEC Form 6-K filed by RELX PLC PLC
- Cytora and LexisNexis Risk Solutions announce strategic relationship to enhance risk selection and automation for U.S. commercial insurers